SSanofi Read More Novavax Reports Second Quarter 2026 Financial Results and Operational HighlightsAugust 10, 2026 Reported total revenue of $57 million for the second quarter of 2026 and raised full-year 2026 Revenue Framework…
SSanofi Read More Sanofi experiencing shortage of two Pompe disease drugsAugust 10, 2026 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
SSanofi Read More Sanofi stock holds after 2026 report contextAugust 9, 2026 Sanofi (FR0000127771) remains a large-cap healthcare name with 2025 revenue, earnings, and dividend data still framing the share…
SSanofi Read More Is Sanofi (ENXTPA:SAN) Cheap Following MenQuadfi Approval For Infants?August 9, 2026 EC approval for MenQuadfi expansion puts Sanofi stock in focus The European Commission has approved an expanded indication…
SSanofi Read More Sanofi SA (SNY) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Upgraded Guidance …August 8, 2026 This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings…
SSanofi Read More Sanofi Appoints Archana Subramanya as Head – R&D India HubAugust 8, 2026 Hyderabad, Telangana, India, August 2026 — Sanofi has appointed Archana Subramanya as Head – R&D India Hub, strengthening…
SSanofi Read More Novavax Boosts Revenue Outlook Amid Vaccine Demand Challenges, ETPharmaAugust 8, 2026 Bengaluru: Novavax raised its annual revenue forecast on Thursday, banking on payments related to the vaccine maker’s licensing…
SSanofi Read More EU Approves Sanofi’s MenQuadfi for Infants as Young as 6 Weeks, Expanding Protection Against a Leading Cause of Acquired DeafnessAugust 7, 2026 The European Commission has expanded the indication for MenQuadfi to include infants from 6 weeks of age, offering…
SSanofi Read More Novavax tops forecasts and raises revenue outlook as Sanofi collaboration progressesAugust 6, 2026 Researcher looking through microscope ©Adobe Stock Images Novavax Inc. (NASDAQ:NVAX) reported second-quarter results that came in ahead of…
SSanofi Read More NAACP, Sanofi Announce Interactive Health Equity Map, Making Nearly 23,000 Community Voices “Impossible to Ignore”August 6, 2026 FOR IMMEDIATE RELEASEAugust 6, 2026Contact: communications@naacpnet.org CHICAGO – During the 117th NAACP National Convention, the NAACP, in collaboration…
SSanofi Read More Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand | WSAU News/Talk 550 AM · 99.9 FMAugust 6, 2026 Aug 6 (Reuters) – Novavax raised its annual revenue forecast after beating quarterly expectations on Thursday, as the…
SSanofi Read More Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal diseaseAugust 6, 2026 Sanofi Winthrop Industrie Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against…